TOPAZIUM Clinical trials allows physicians
to simultaneously map genetic, chemical, biochemistry
and clinical patient’s conditions to identify
“super-responders” or “super-resistant” clusters
in a clinical study.
< RETURN TO PIPELINE

TOPAZIUM Clinical trials allows physicians to simultaneously map genetic, chemical, biochemistry and clinical patient’s conditions to identify “super-responders” or “super-resistant” clusters in a clinical study.

TOPAZIUM Clinical trials allows physicians to simultaneously map genetic, chemical, biochemistry and clinical patient’s conditions to identify “super-responders” or “super-resistant” clusters in a clinical study.

  Study type D&D
Design &
Development
T&T
Training &
Testing
A&A
Availability &
Access
Cancer Phase III  

Need more information?

CONTACT US